Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120112) titled 'Clinical trials evaluating the safety and efficacy of prostate biopsy planning software' on March 9.
Study Type: Diagnostic test
Study Design:
Cross-over
Primary Sponsor: The First Medical Center of Chinese PLA general hospital
Condition:
prostate cancer
Intervention:
Gold Standard:This clinical trial uses the target puncture area results ultimately outlined by the expert panel as the gold standard.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-09
Target Sample Size: Target condition:176;Difficult condition:0
Countries of Recruitment:
China
To know more, visit h...